ArticleBMC medicine2021

Combined homologous recombination repair deficiency and immune activation analysis for predicting intensified responses of anthracycline, cyclophosphamide and taxane chemotherapy in triple-negative breast cancer.

Gaoming Liao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.